JP2022088631A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2022088631A5 JP2022088631A5 JP2022062741A JP2022062741A JP2022088631A5 JP 2022088631 A5 JP2022088631 A5 JP 2022088631A5 JP 2022062741 A JP2022062741 A JP 2022062741A JP 2022062741 A JP2022062741 A JP 2022062741A JP 2022088631 A5 JP2022088631 A5 JP 2022088631A5
- Authority
- JP
- Japan
- Prior art keywords
- bacterial strain
- composition according
- rrna gene
- gene sequence
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (16)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18171893 | 2018-05-11 | ||
| EP18171893.3 | 2018-05-11 | ||
| EP18178136.0 | 2018-06-15 | ||
| EP18178136 | 2018-06-15 | ||
| GBGB1810386.1A GB201810386D0 (en) | 2018-06-25 | 2018-06-25 | Compositions comprising bacterial strains |
| GB1810386.1 | 2018-06-25 | ||
| GB1813460.1 | 2018-08-17 | ||
| GBGB1813460.1A GB201813460D0 (en) | 2018-08-17 | 2018-08-17 | Compositions comprising bacterial strains |
| GB1817642.0 | 2018-10-29 | ||
| GBGB1817642.0A GB201817642D0 (en) | 2018-10-29 | 2018-10-29 | Compositions comprising bacterial strains |
| GBGB1820256.4A GB201820256D0 (en) | 2018-12-12 | 2018-12-12 | Compositions comprising bacterial strains |
| GBGB1820264.8A GB201820264D0 (en) | 2018-12-12 | 2018-12-12 | Compositions comprising bacterial strains |
| GB1820264.8 | 2018-12-12 | ||
| GB1820256.4 | 2018-12-12 | ||
| PCT/EP2019/062238 WO2019215346A1 (en) | 2018-05-11 | 2019-05-13 | Compositions comprising bacterial strains |
| JP2020545563A JP7058449B2 (ja) | 2018-05-11 | 2019-05-13 | 細菌株を含む組成物 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020545563A Division JP7058449B2 (ja) | 2018-05-11 | 2019-05-13 | 細菌株を含む組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022088631A JP2022088631A (ja) | 2022-06-14 |
| JP2022088631A5 true JP2022088631A5 (enExample) | 2022-06-28 |
Family
ID=66597549
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020545563A Expired - Fee Related JP7058449B2 (ja) | 2018-05-11 | 2019-05-13 | 細菌株を含む組成物 |
| JP2020562128A Pending JP2021523895A (ja) | 2018-05-11 | 2019-05-13 | 細菌株を含む組成物 |
| JP2022062741A Pending JP2022088631A (ja) | 2018-05-11 | 2022-04-05 | 細菌株を含む組成物 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020545563A Expired - Fee Related JP7058449B2 (ja) | 2018-05-11 | 2019-05-13 | 細菌株を含む組成物 |
| JP2020562128A Pending JP2021523895A (ja) | 2018-05-11 | 2019-05-13 | 細菌株を含む組成物 |
Country Status (23)
| Country | Link |
|---|---|
| US (3) | US11419902B2 (enExample) |
| EP (4) | EP4056192A1 (enExample) |
| JP (3) | JP7058449B2 (enExample) |
| KR (2) | KR20210008391A (enExample) |
| CN (2) | CN112512539A (enExample) |
| AU (3) | AU2019267170A1 (enExample) |
| BR (1) | BR112020022833A2 (enExample) |
| CA (2) | CA3098971A1 (enExample) |
| CY (1) | CY1125211T1 (enExample) |
| DK (1) | DK3743086T3 (enExample) |
| ES (1) | ES2916601T3 (enExample) |
| HR (1) | HRP20220578T1 (enExample) |
| IL (1) | IL278471B2 (enExample) |
| LT (1) | LT3743086T (enExample) |
| MD (1) | MD3743086T2 (enExample) |
| MX (1) | MX2020012061A (enExample) |
| PL (1) | PL3743086T3 (enExample) |
| RS (1) | RS63273B1 (enExample) |
| SG (2) | SG11202011028SA (enExample) |
| SI (1) | SI3743086T1 (enExample) |
| SM (1) | SMT202200217T1 (enExample) |
| TW (2) | TW202014513A (enExample) |
| WO (2) | WO2019215345A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2019009071A (es) | 2017-01-31 | 2019-11-12 | Univ Kansas State | Celulas microbianas, metodos para producir las mismas, y usos de las mismas. |
| SMT202000555T1 (it) | 2017-06-14 | 2020-11-10 | 4D Pharma Res Limited | Composizioni comprendenti un ceppo batterico del genere megaspaera e loro usi |
| EP3697220A4 (en) | 2017-10-20 | 2021-08-11 | MS Biotech, Inc. | PROCESS FOR PRODUCING SILAGED PLANT MATERIAL USING MEGASPHAERA ELSDENII |
| PL3743086T3 (pl) | 2018-05-11 | 2022-06-20 | 4D Pharma Research Limited | Kompozycje zawierające szczepy bakteryjne |
| US11541105B2 (en) | 2018-06-01 | 2023-01-03 | The Research Foundation For The State University Of New York | Compositions and methods for disrupting biofilm formation and maintenance |
| JP2022511975A (ja) * | 2018-12-12 | 2022-02-01 | フォーディー ファーマ リサーチ リミテッド | 細菌株を含む組成物 |
| TW202038979A (zh) * | 2018-12-12 | 2020-11-01 | 英商4D製藥研究有限公司 | 包含細菌菌株之組成物 |
| WO2021252861A1 (en) * | 2020-06-11 | 2021-12-16 | Evelo Biosciences, Inc. | Compositions and methods for treating diseases and disorders using megasphaera sp |
| CN112877275B (zh) * | 2021-02-04 | 2023-03-31 | 中国农业科学院兰州兽医研究所 | Hdac2基因敲除的bhk-21细胞系及其构建方法和应用 |
| CN112980878B (zh) * | 2021-02-04 | 2023-03-31 | 中国农业科学院兰州兽医研究所 | Hdac8基因敲除的bhk-21细胞系及其构建方法和应用 |
| EP4520816A1 (en) | 2022-04-28 | 2025-03-12 | Moon (Guangzhou) Biotech Co., Ltd. | Pharmaceutical composition, megasphaera, and use thereof |
| EP4516892A1 (en) | 2022-04-28 | 2025-03-05 | Moon (Guangzhou) Biotech Co., Ltd. | Pharmaceutical composition, megasphaera, and use thereof |
| KR102551061B1 (ko) * | 2022-05-26 | 2023-07-03 | 중앙대학교 산학협력단 | Saha를 유효성분으로 포함하는 살모넬라 속 균주에 의한 바이오필름 생성 저해용 조성물 |
| CN117018036B (zh) * | 2023-07-28 | 2025-09-05 | 深圳未知君生物科技有限公司 | 巨球形菌属细菌在制备治疗癌症的药物中的应用 |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5557520A (en) * | 1978-10-26 | 1980-04-28 | Nisshin Flour Milling Co Ltd | Preparation of carcinostatic substance |
| EP1389464A4 (en) | 2001-04-06 | 2005-06-22 | Combi Co | COMPOSITIONS WITH A BACTERIUM THAT MAY CONVERT MILKYLIC ACID TO BUTTERIC ACID, AND METHOD FOR THE PREVENTION / TREATMENT OF HYPERLACTACIDEMIA IN CARCINOMA IN DIGESTIVE TRAIN AND COLON USING THESE COMPOSITIONS |
| GB0127916D0 (en) | 2001-11-21 | 2002-01-16 | Rowett Res Inst | Method |
| US20040005304A1 (en) | 2002-07-08 | 2004-01-08 | Mak Wood, Inc. | Novel compositions and methods for treating neurological disorders and associated gastrointestinal conditions |
| GB0307026D0 (en) * | 2003-03-27 | 2003-04-30 | Rowett Res Inst | Bacterial supplement |
| CN102349927A (zh) | 2003-08-29 | 2012-02-15 | Hdac默克研究有限责任公司 | 联合治疗癌症的方法 |
| GB201112091D0 (en) | 2011-07-14 | 2011-08-31 | Gt Biolog Ltd | Bacterial strains isolated from pigs |
| GB201117313D0 (en) | 2011-10-07 | 2011-11-16 | Gt Biolog Ltd | Bacterium for use in medicine |
| SG11201503966PA (en) | 2012-11-23 | 2015-06-29 | Seres Health Inc | Synergistic bacterial compositions and methods of production and use thereof |
| US10973861B2 (en) | 2013-02-04 | 2021-04-13 | Seres Therapeutics, Inc. | Compositions and methods |
| GB201306536D0 (en) | 2013-04-10 | 2013-05-22 | Gt Biolog Ltd | Polypeptide and immune modulation |
| WO2015010096A1 (en) * | 2013-07-18 | 2015-01-22 | Baylor College Of Medicine | Method of enhancing potency of immune cells |
| CN104415060A (zh) * | 2013-08-30 | 2015-03-18 | 深圳华大基因科技有限公司 | 可食用组合物及其制备方法和用途 |
| US10203329B2 (en) * | 2013-09-12 | 2019-02-12 | The Johns Hopkins University | Biofilm formation to define risk for colon cancer |
| CN105979952B (zh) | 2013-11-25 | 2022-04-08 | 赛里斯治疗公司 | 协同细菌组合物以及其制造方法和用途 |
| US9650654B2 (en) * | 2014-06-25 | 2017-05-16 | William Marsh Rice University | Making C4+ products in bacteria |
| US10366793B2 (en) * | 2014-10-21 | 2019-07-30 | uBiome, Inc. | Method and system for characterizing microorganism-related conditions |
| WO2016073381A1 (en) * | 2014-11-03 | 2016-05-12 | Cerus Corporation | Compositions and methods for improved car-t cell therapies |
| MA41020A (fr) * | 2014-11-25 | 2017-10-03 | Evelo Biosciences Inc | Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome |
| US10231941B2 (en) * | 2015-01-23 | 2019-03-19 | Temple University—Of The Commonwealth System of Higher Educaton | Use of short chain fatty acids in cancer prevention |
| WO2016149449A1 (en) | 2015-03-18 | 2016-09-22 | Tufts University | Compositions and methods for preventing colorectal cancer |
| MA41060B1 (fr) | 2015-06-15 | 2019-11-29 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
| CN108513545B (zh) * | 2015-11-20 | 2020-11-03 | 4D制药研究有限公司 | 包含细菌菌株的组合物 |
| PL3380108T3 (pl) * | 2015-11-24 | 2023-03-27 | Seres Therapeutics, Inc. | Zaprojektowane kompozycje bakteryjne |
| WO2017122197A1 (en) * | 2016-01-11 | 2017-07-20 | 3Plw Ltd. | Lactic acid-utilizing bacteria genetically modified to secrete polysaccharide-degrading enzymes |
| CN107028985A (zh) * | 2016-02-04 | 2017-08-11 | 深圳华大基因研究院 | 厚壁菌类益生菌在预防和/或治疗糖尿病及其相关疾病中的应用 |
| WO2017172894A2 (en) * | 2016-03-30 | 2017-10-05 | The Trustees Of Columbia University In The City Of New York | Methods of preventing, treating and detecting colorectal cancer using butyrate producing bacteria |
| US9999641B2 (en) * | 2016-06-14 | 2018-06-19 | Vedanta Biosciences, Inc. | Treatment of clostridium difficile infection |
| KR102708641B1 (ko) * | 2016-09-27 | 2024-09-24 | 더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 | 미생물유전체를 조정함으로써 면역 체크포인트 차단 요법을 증강시키는 방법 |
| WO2018094190A2 (en) | 2016-11-18 | 2018-05-24 | Sanford Burnham Prebys Medical Discovery Institute | Gut microbiota and treatment of cancer |
| US20190314427A1 (en) | 2016-12-16 | 2019-10-17 | Evelo Biosciences, Inc. | Methods of treating cancer using parabacteroides |
| WO2018112365A2 (en) | 2016-12-16 | 2018-06-21 | Evelo Biosciences, Inc. | Methods of treating colorectal cancer and melanoma using parabacteroides goldsteinii |
| CA3066189A1 (en) * | 2017-06-14 | 2018-12-20 | 4D Pharma Research Limited | Compositions comprising bacterial strains |
| SMT202000555T1 (it) * | 2017-06-14 | 2020-11-10 | 4D Pharma Res Limited | Composizioni comprendenti un ceppo batterico del genere megaspaera e loro usi |
| PL3743086T3 (pl) * | 2018-05-11 | 2022-06-20 | 4D Pharma Research Limited | Kompozycje zawierające szczepy bakteryjne |
| TW202038979A (zh) | 2018-12-12 | 2020-11-01 | 英商4D製藥研究有限公司 | 包含細菌菌株之組成物 |
| JP2022511975A (ja) * | 2018-12-12 | 2022-02-01 | フォーディー ファーマ リサーチ リミテッド | 細菌株を含む組成物 |
-
2019
- 2019-05-13 PL PL19725068T patent/PL3743086T3/pl unknown
- 2019-05-13 SI SI201930216T patent/SI3743086T1/sl unknown
- 2019-05-13 EP EP22162255.8A patent/EP4056192A1/en active Pending
- 2019-05-13 AU AU2019267170A patent/AU2019267170A1/en not_active Abandoned
- 2019-05-13 JP JP2020545563A patent/JP7058449B2/ja not_active Expired - Fee Related
- 2019-05-13 WO PCT/EP2019/062236 patent/WO2019215345A1/en not_active Ceased
- 2019-05-13 SG SG11202011028SA patent/SG11202011028SA/en unknown
- 2019-05-13 CN CN201980031512.5A patent/CN112512539A/zh active Pending
- 2019-05-13 EP EP19725067.3A patent/EP3790564A1/en not_active Withdrawn
- 2019-05-13 MX MX2020012061A patent/MX2020012061A/es unknown
- 2019-05-13 EP EP22162425.7A patent/EP4066845A1/en active Pending
- 2019-05-13 DK DK19725068.1T patent/DK3743086T3/da active
- 2019-05-13 KR KR1020207035242A patent/KR20210008391A/ko not_active Ceased
- 2019-05-13 BR BR112020022833-8A patent/BR112020022833A2/pt not_active IP Right Cessation
- 2019-05-13 SG SG11202011031UA patent/SG11202011031UA/en unknown
- 2019-05-13 HR HRP20220578TT patent/HRP20220578T1/hr unknown
- 2019-05-13 TW TW108116449A patent/TW202014513A/zh unknown
- 2019-05-13 LT LTEPPCT/EP2019/062238T patent/LT3743086T/lt unknown
- 2019-05-13 JP JP2020562128A patent/JP2021523895A/ja active Pending
- 2019-05-13 EP EP19725068.1A patent/EP3743086B1/en active Active
- 2019-05-13 RS RS20220465A patent/RS63273B1/sr unknown
- 2019-05-13 AU AU2019267171A patent/AU2019267171A1/en not_active Abandoned
- 2019-05-13 SM SM20220217T patent/SMT202200217T1/it unknown
- 2019-05-13 KR KR1020207035244A patent/KR20210008393A/ko not_active Ceased
- 2019-05-13 CN CN201980031147.8A patent/CN112601534A/zh active Pending
- 2019-05-13 CA CA3098971A patent/CA3098971A1/en active Pending
- 2019-05-13 WO PCT/EP2019/062238 patent/WO2019215346A1/en not_active Ceased
- 2019-05-13 ES ES19725068T patent/ES2916601T3/es active Active
- 2019-05-13 TW TW108116469A patent/TW202011975A/zh unknown
- 2019-05-13 CA CA3099209A patent/CA3099209A1/en active Pending
- 2019-05-13 MD MDE20201221T patent/MD3743086T2/ro not_active IP Right Cessation
-
2020
- 2020-09-04 US US17/013,026 patent/US11419902B2/en active Active
- 2020-11-03 IL IL278471A patent/IL278471B2/en unknown
- 2020-11-11 US US17/095,427 patent/US20210275605A1/en not_active Abandoned
-
2022
- 2022-04-05 JP JP2022062741A patent/JP2022088631A/ja active Pending
- 2022-05-27 CY CY20221100367T patent/CY1125211T1/el unknown
- 2022-06-23 US US17/847,336 patent/US20230158083A1/en not_active Abandoned
-
2023
- 2023-02-03 AU AU2023200562A patent/AU2023200562A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022088631A5 (enExample) | ||
| JP2021523895A5 (enExample) | ||
| Wang et al. | A purified membrane protein from Akkermansia muciniphila or the pasteurised bacterium blunts colitis associated tumourigenesis by modulation of CD8+ T cells in mice | |
| HRP20220578T1 (hr) | Pripravci koji sadrže bakterijske sojeve | |
| Alzahrani et al. | Effect of Helicobacter pylori on gastric epithelial cells | |
| AU2017200541B2 (en) | Pseudomonas exotoxin A with less immunogenic T cell and/or B cell epitopes | |
| JP2018518974A5 (enExample) | ||
| US10111927B2 (en) | Pseudomonas exotoxin A with less immunogenic B cell epitopes | |
| JP2019522973A5 (enExample) | ||
| Sharma et al. | Role of probiotics in the management of lung cancer and related diseases: An update | |
| Fredriksen et al. | Cell wall anchoring of the 37-kilodalton oncofetal antigen by Lactobacillus plantarum for mucosal cancer vaccine delivery | |
| JP2024531409A5 (enExample) | ||
| JP2010508847A5 (enExample) | ||
| JP2010516708A5 (enExample) | ||
| Chen et al. | Gene polymorphisms of pathogenic Helicobacter pylori in patients with different types of gastrointestinal diseases | |
| US20210254005A1 (en) | Off-the-shelf stem cell and immune cell, and a pharmaceutical composition including the same | |
| Han et al. | Interleukin-32: Frenemy in cancer? | |
| de Brito et al. | Role of polymorphisms in genes that encode cytokines and Helicobacter pylori virulence factors in gastric carcinogenesis | |
| Amedei et al. | T cells in gastric cancer: friends or foes | |
| Teng et al. | Anti-IL-23 monoclonal antibody synergizes in combination with targeted therapies or IL-2 to suppress tumor growth and metastases | |
| Ting et al. | Chang Wei Qing Decoction enhances the anti-tumor effect of PD-1 inhibitor therapy by regulating the immune microenvironment and gut microbiota in colorectal cancer | |
| JP2018522041A5 (enExample) | ||
| JP2023510121A5 (enExample) | ||
| CN113207282A (zh) | 用于治疗癌症的包含副拟杆菌属细菌菌株的组合物 | |
| de Souza Gonçalves et al. | From Helicobacter pylori infection to gastric cancer: Current evidence on the immune response |